Pregnancies, live births, and heart structure and function in women with HIV

AIDS Res Ther. 2026 Jan 25. doi: 10.1186/s12981-025-00842-5. Online ahead of print.ABSTRACTOBJECTIVE: Women with HIV (WWH) have up to five times higher risk for cardiovascular disease compared to age-matched women without HIV, and this risk is pronounced in reproductive-aged women. Pregnancy promote

Y Yue Pan

Prevalence of elevated lipoprotein(a) levels and associated atherosclerotic cardiovascular diseases in subjects with metabolic disorders: A real-world study in a lipid unit

Clin Investig Arterioscler. 2026 Jan 24:500892. doi: 10.1016/j.arteri.2026.500892. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Lipoprotein(a) (Lp(a)) is a proatherogenic particle that is considered an important cardiovascular risk modifier due to its association with atherosclerotic cardiovas

F Francesco Di Giacomo Barbagallo

Nucleic acid based therapies - the next frontier in treating dyslipidemias

Can J Cardiol. 2026 Jan 23:S0828-282X(26)00054-1. doi: 10.1016/j.cjca.2026.01.026. Online ahead of print.ABSTRACTGenetic determinants play a central role in the development of dyslipidemias, which are major contributors to atherosclerotic cardiovascular disease (ASCVD), aortic valve disease, and acu

R Robert A Hegele

The Role of Glutamine Metabolism in Cardiovascular Diseases

Eur J Pharmacol. 2026 Jan 23:178600. doi: 10.1016/j.ejphar.2026.178600. Online ahead of print.ABSTRACTCardiovascular disease (CVD) is a major public health issue causing high mortality rates worldwide. Its pathogenesis is complex and diverse, its treatment costs are high, and it represents a serious

Y Yuqing Li